Literature DB >> 35311520

Macrolide Resistance in Mycoplasma pneumoniae, Midwestern United States, 2014 to 2021.

Tanner E Rothstein1, Scott A Cunningham1, Rachelle A Rieke1, Jill M Mainella1, Melissa M Mutchler1, Robin Patel1,2.   

Abstract

The epidemiology of macrolide resistance in Mycoplasma (Mycoplasmoides) pneumoniae in the United States is incompletely described. Using a PCR assay targeting common mutations associated with macrolide resistance in M. pneumoniae (23S rRNA gene, A2063G/A2064G), the frequency of macrolide resistance was estimated to be 10% based on analysis of 114 samples tested from January 2014 to September 2021 at Mayo Clinic Laboratories. Seasonality data showed the highest rates of M. pneumoniae infection in the fall/early winter.

Entities:  

Keywords:  Mycoplasma pneumoniae; antibiotic resistance; macrolides; pneumonia; surveillance studies

Mesh：

Substances：

Year:  2022        PMID： 35311520      PMCID： PMC9017374          DOI： 10.1128/aac.02432-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.938


  9 in total

1.  New insights in the outbreak pattern of Mycoplasma pneumoniae.

Authors:  Enno Jacobs; Ingrid Ehrhardt; Roger Dumke
Journal:  Int J Med Microbiol       Date:  2015-08-22       Impact factor: 3.473

2.  Real-time PCR detection of Mycoplasma pneumoniae in respiratory specimens.

Authors:  Bryan H Schmitt; Lynne M Sloan; Robin Patel
Journal:  Diagn Microbiol Infect Dis       Date:  2013-09-14       Impact factor: 2.803

Review 3.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

4.  Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program.

Authors:  K B Waites; A Ratliff; D M Crabb; L Xiao; X Qin; R Selvarangan; Y-W Tang; X Zheng; J Dien Bard; T Hong; M Prichard; E Brooks; S Dallas; L Duffy; E Mixon; K B Fowler; T P Atkinson
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

5.  Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis.

Authors:  O Peuchant; A Ménard; H Renaudin; M Morozumi; K Ubukata; C M Bébéar; S Pereyre
Journal:  J Antimicrob Chemother       Date:  2009-05-09       Impact factor: 5.790

6.  Impact of weather factors on Mycoplasma pneumoniae pneumonia.

Authors:  D Onozuka; M Hashizume; A Hagihara
Journal:  Thorax       Date:  2009-03-23       Impact factor: 9.139

7.  Macrolide-Resistant Mycoplasma pneumoniae Infections in Children, Ohio, USA.

Authors:  Mariana M Lanata; Huanyu Wang; Kathy Everhart; Melisa Moore-Clingenpeel; Octavio Ramilo; Amy Leber
Journal:  Emerg Infect Dis       Date:  2021-06       Impact factor: 6.883

Review 8.  The Evolution of Advanced Molecular Diagnostics for the Detection and Characterization of Mycoplasma pneumoniae.

Authors:  Maureen H Diaz; Jonas M Winchell
Journal:  Front Microbiol       Date:  2016-03-08       Impact factor: 5.640

Review 9.  Mycoplasma pneumoniae: Current Knowledge on Nucleic Acid Amplification Techniques and Serological Diagnostics.

Authors:  Katherine Loens; Margareta Ieven
Journal:  Front Microbiol       Date:  2016-03-31       Impact factor: 5.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.